Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Sleep Medicine ClinicsAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Melatonin and its agonists: an update.Br J Psychiatry. 2008; 193: 267-269
- Free-running activity rhythms in the rat: entrainment by melatonin.Science. 1983; 219: 1089-1091
- Some effects of melatonin and the control of its secretion in humans.Ciba Found Symp. 1985; 117: 266-283
- Suprachiasmatic control of melatonin synthesis in rats: inhibitory and stimulatory mechanisms.Eur J Neurosci. 2003; 17: 221-228
- Glutamatergic clock output stimulates melatonin synthesis at night.Eur J Neurosci. 2004; 19: 318-324
- Effects of damage to the suprachiasmatic area of the anterior hypothalamus on the daily melatonin and cortisol rhythms in the rhesus monkey.J Neurosci. 1981; 1: 1414-1425
- Pineal N-acetyltransferase and hydroxyindole-O-methyltransferase: control by the retinohypothalamic tract and the suprachiasmatic nucleus.Brain Res. 1979; 174: 245-262
- Physiological effects of melatonin: role of melatonin receptors and signal transduction pathways.Prog Neurobiol. 2008; 85: 335-353
- Entrainment of rat circadian rhythms by daily injection of melatonin depends upon the hypothalamic suprachiasmatic nuclei.Physiol Behav. 1986; 36: 1111-1121
- Melatonin instantaneously resets intrinsic circadian rhythmicity in the rat suprachiasmatic nucleus.Neurosci Lett. 1996; 218: 181-184
- Effects of melatonin on 2-deoxy-[1-14C] glucose uptake within rat suprachiasmatic nucleus.Am J Phys. 1988; 255: R332-R337
- CREB in the mouse SCN: a molecular interface coding the phase-adjusting stimuli light, glutamate, PACAP, and melatonin for clockwork access.J Neurosci. 1998; 18: 10389-10397
- The pituitary adenylate cyclase-activating polypeptide-induced phosphorylation of the transcription factor CREB (cAMP response element binding protein) in the rat suprachiasmatic nucleus is inhibited by melatonin.Neurosci Lett. 1997; 227: 145-148
- Melatonin receptors step into the light: cloning and classification of subtypes.Trends Pharmacol Sci. 1996; 17: 100-102
- Molecular dissection of two distinct actions of melatonin on the suprachiasmatic circadian clock.Neuron. 1997; 19: 91-102
- Activation of MT(2) melatonin receptors in rat suprachiasmatic nucleus phase advances the circadian clock.Am J Physiol Cell Physiol. 2001; 280: C110-C118
- Selective MT2 melatonin receptor antagonists block melatonin-mediated phase advances of circadian rhythms.FASEB J. 1998; 12: 1211-1220
- Effect of MT1 melatonin receptor deletion on melatonin-mediated phase shift of circadian rhythms in the C57BL/6 mouse.J Pineal Res. 2005; 39: 113-120
- Melatonin limits transcriptional impact of phosphoCREB in the mouse SCN via the Mel1a receptor.Neuroreport. 2000; 11: 1803-1807
- Melatonin receptors: role on sleep and circadian rhythm regulation.Sleep Med. 2007; 8: 34-42
- Effects of melatonin on neuronal activity in the rat suprachiasmatic nucleus in vitro.Neurosci Lett. 1989; 97: 140-144
- Targeted disruption of the mouse Mel(1b) melatonin receptor.Mol Cell Biol. 2003; 23: 1054-1060
- Effects of melatonin on human mood and performance.Brain Res. 1984; 323: 201-207
- Potential action of melatonin in insomnia.Sleep. 2003; 26: 1058-1059
- The role of melatonin and circadian phase in age-related sleep-maintenance insomnia: assessment in a clinical trial of melatonin replacement.Sleep. 1998; 21: 52-68
- Melatonin-induced temperature suppression and its acute phase-shifting effects correlate in a dose-dependent manner in humans.Brain Res. 1995; 688: 77-85
- Effect of inducing nocturnal serum melatonin concentrations in daytime on sleep, mood, body temperature, and performance.Proc Natl Acad Sci U S A. 1994; 91: 1824-1828
- Efficacy and safety of exogenous melatonin for secondary sleep disorders and sleep disorders accompanying sleep restriction: meta-analysis.BMJ. 2006; 332: 385-393
- Melatonin for the prevention and treatment of jet lag (Cochrane Review).Cochrane Database Syst Rev. 2002; (CD001520)
- The efficacy and safety of exogenous melatonin for primary sleep disorders: a meta-analysis.J Gen Intern Med. 2005; 20: 1151-1158
- Plasma concentrations of melatonin in man following oral absorption of different preparations.Br J Clin Pharmacol. 1985; 19: 517-521
- Bioavailability of oral melatonin in humans.Neuroendocrinology. 1984; 39: 307-313
- Circadian entrainment and phase shifting in mammals with melatonin.J Biol Rhythms. 1997; 12: 581-587
- Melatonin and signal transduction in the rat suprachiasmatic circadian clock: activation of protein kinase C at dawn and dusk.Endocrinology. 1997; 138: 627-634
- Complex effects of melatonin: evidence for photoperiodic responses in humans?.Sleep. 1999; 22: 625-635
- A three pulse phase response curve to three milligrams of melatonin in humans.J Physiol. 2008; 586: 639-647
- The human phase response curve (PRC) to melatonin is about 12 hours out of phase with the PRC to light.Chronobiol Int. 1998; 15: 71-83
- Melatonin is able to influence its secretion in humans: description of a phase response curve.Neuroendocrinology. 1994; 60: 105-112
- No evidence for a phase delay in human circadian rhythms after a single morning melatonin administration.J Pineal Res. 2002; 32: 1-5
- Free-running melatonin rhythms in blind people: phase shifts with melatonin and triazolam administration.in: Rensing L. van der Heiden U. Mackey M.C. Temporal disorder in human oscillatory systems. Springer-Verlag, Heidelberg1987: 219-224
- Acute phase-shifting effects of melatonin associated with suppression of core body temperature in humans.Neurosci Lett. 1994; 178: 32-34
- Melatonin phase advances circadian rhythm.Psychopharmacology (Berl). 1995; 121: 503-505
- Early evening melatonin and S-20098 advance circadian phase and nocturnal regulation of core body temperature.Am J Phys. 1997; 272: R1178-R1188
- Melatonin phase shifts human circadian rhythms in a placebo-controlled simulated night-work study.Am J Physiol Regul Integr Comp Physiol. 2002; 282: R454-R463
- Melatonin phase shifts human circadian rhythms with no evidence of changes in the duration of endogenous melatonin secretion or the 24-hour production of reproductive hormones.J Clin Endocrinol Metab. 2003; 88: 4303-4309
- Robust circadian rhythm in heart rate and its variability: influence of exogenous melatonin and photoperiod.J Sleep Res. 2007; 16: 148-155
- Melatonin advances the circadian timing of EEG sleep and directly facilitates sleep without altering its duration in extended sleep opportunities in humans.J Physiol. 2004; 561: 339-351
- Melatonin administration can entrain the free-running circadian system of blind subjects.J Endocrinol. 2000; 164: R1-R6
- Entrainment of free-running circadian rhythms by melatonin in blind people.N Engl J Med. 2000; 343: 1070-1077
- Low, but not high, doses of melatonin entrained a free-running blind person with a long circadian period.Chronobiol Int. 2002; 19: 649-658
- The effects of low-dose 0.5-mg melatonin on the free-running circadian rhythms of blind subjects.J Biol Rhythms. 2003; 18: 420-429
- Melatonin entrains free-running blind people according to a physiological dose-response curve.Chronobiol Int. 2005; 22: 1093-1106
- Effects of melatonin administration on daytime sleep after simulated night shift work.J Sleep Res. 2001; 10: 181-192
- Delayed sleep phase syndrome: response to melatonin.Lancet. 1991; 337: 1121-1124
- Can melatonin improve shift workers' tolerance of the night shift? Some preliminary findings.Chronobiol Int. 1993; 10: 315-320
- Efficacy of melatonin treatment in jet lag, shift work, and blindness.J Biol Rhythms. 1997; 12: 604-617
- Delayed sleep phase syndrome: a placebo-controlled cross-over study on the effects of melatonin administered five hours before the individual dim light melatonin onset.J Sleep Res. 1998; 7: 135-143
- Improving adaptation to simulated night shift: timed exposure to bright light versus daytime melatonin administration.Sleep. 1995; 18: 11-21
- Jet lag: clinical features, validation of a new syndrome-specific scale, and lack of response to melatonin in a randomized, double-blind trial.Am J Psychiatry. 1999; 156: 1392-1396
- Does melatonin improve sleep? Efficacy of melatonin.BMJ. 2006; 332: 550
- Sleep propensity free-runs with the temperature, melatonin and cortisol rhythms in a totally blind person.Sleep. 1992; 15: 330-336
- Melatonin and the circadian regulation of sleep initiation, consolidation, structure, and the sleep EEG.J Biol Rhythms. 1997; 12: 627-635
- Relationship between napping and melatonin in the blind.J Biol Rhythms. 1997; 12: 16-25
- Circadian temperature and melatonin rhythms, sleep, and neurobehavioral function in humans living on a 20-h day.Am J Physiol. 1999; 277 (Regulatory, Integrative and Comparative Physiology): R1152-R1163
- Evidence for a biological dawn and dusk in the human circadian timing system.J Physiol. 2001; 535: 937-951
- Reduced sleep efficiency in cervical spinal cord injury: association with abolished night time melatonin secretion.Spinal Cord. 2006; 44: 78-81
- Endogenous versus exogenous effects of melatonin.in: Pandi-Perumal S.R. Cardinali D.P. Melatonin: from molecules to therapy. Nova Science Publishers, New York2007: 547-569
- On the effects of melatonin on sleep and behavior in man.Adv Biochem Psychopharmacol. 1974; 11: 187-191
- On the effect of melatonin upon human brain: its possible therapeutic implications.Life Sci. 1971; 1015: 841-850
- Evening administration of melatonin and bright light: interactions on the EEG during sleep and wakefulness.J Sleep Res. 1998; 7: 145-157
- Sleep-promoting and hypothermic effects of daytime melatonin administration in humans.Sleep. 1997; 20: 124-131
- Hypnotic and hypothermic action of daytime-administered melatonin.Psychopharmacol. 1997; 133: 168-171
- Melatonin improves evening napping.Eur J Pharmacol. 1995; 275: 213-216
- Effects of low oral doses of melatonin, given 2-4 hours before habitual bedtime, on sleep in normal young humans.Sleep. 1996; 19: 423-431
- Day-time melatonin administration: effects on core temperature and sleep onset latency.J Sleep Res. 1996; 5: 150-154
- Daytime melatonin and temazepam in young adult humans: equivalent effects on sleep latency and body temperatures.J Physiol. 1999; 514: 905-914
- Sleep-facilitating effect of exogenous melatonin in healthy young men and women is circadian-phase dependent.Sleep. 2006; 29: 609-618
- Sleep laboratory investigations on hypnotic properties of melatonin.Psychopharmacology (Berl). 1990; 100: 222-226
- Low dose melatonin improves sleep in healthy middle-aged subjects.Psychopharmacology (Berl). 1996; 126: 179-181
- Melatonin and S-20098 increase REM sleep and wake-up propensity without modifying NREM sleep homeostasis.Am J Phys. 1997; 272: R1189-R1196
- Effect of sustained nocturnal transbuccal melatonin administration on sleep and temperature in elderly insomniacs.J Biol Rhythms. 1998; 13: 532-538
- Melatonin and fragmented sleep patterns.Lancet. 1996; 348: 551-552
- Hypnotic and hypothermic effects of melatonin on daytime sleep in humans: lack of antagonism by flumazenil.Neurosci Lett. 1996; 214: 123-126
- Melatonin possesses time-dependent hypnotic effects.Sleep. 1994; 17: 638-645
- Efficacy of melatonin as a sleep-promoting agent.J Biol Rhythms. 1997; 12: 644-650
- Melatonin effect on daytime sleep in men: suppression of EEG low frequency activity and enhancement of spindle frequency activity.Neurosci Lett. 1995; 201: 13-16
- Hypnotic activity of melatonin.Sleep. 2000; 23: 663-669
- Ultrashort sleep-waking schedule. III. ‘Gates’ and ‘forbidden zones’ for sleep.Electroencephalogr Clin Neurophysiol. 1986; 63: 414-425
- Circadian regulation dominates homeostatic control of sleep length and prior wake length in humans.Sleep. 1986; 9: 353-364
- Improvement of sleep quality in elderly people by controlled-release melatonin.Lancet. 1995; 346: 541-544
- Melatonin replacement therapy of elderly insomniacs.Sleep. 1995; 18: 598-603
- The effects of exogenous melatonin on the total sleep time and daytime alertness of chronic insomniacs: a preliminary study.Biol Psychiatry. 1991; 30: 371-376
- Improvement of sleep quality by melatonin.Lancet. 1995; 346: 1491
- Melatonin treatment for age-related insomnia.J Clin Endocrinol Metab. 2001; 86: 4727-4730
- Melatonin and insomnia.J Sleep Res. 1996; 5: 61-65
- Melatonin administration in insomnia.Neuropsychopharmacology. 1990; 3: 19-23
- Circadian rhythm sleep disorders (CRSD) in psychiatry: a review.Isr J Psychiatry Relat Sci. 2002; 39: 19-27
- Afferents to the ventrolateral preoptic nucleus.J Neurosci. 2002; 22: 977-990
- Indirect projections from the suprachiasmatic nucleus to major arousal-promoting cell groups in rat: implications for the circadian control of behavioural state.Neurosci. 2005; 130: 165-183
- A neural circuit for circadian regulation of arousal.Nat Neurosci. 2001; 4: 732-738
- Convergence of circadian and sleep regulatory mechanisms on hypocretin-1.Neuroscience. 2004; 129: 727-732
- Circadian and homeostatic regulation of hypocretin in a primate model: implications for the consolidation of wakefulness.J Neurosci. 2003; 23: 3555-3560
- Lesions of the suprachiasmatic nucleus eliminate the daily rhythm of hypocretin-1 release.Sleep. 2004; 27: 619-627
- Role of melatonin in the regulation of human circadian rhythms and sleep.J Neuroendocrinol. 2003; 15: 432-437
- Melatonin: a major regulator of the circadian rhythm of core temperature in humans.J Clin Endocrinol Metab. 1992; 75: 447-452
- Warm feet promote the rapid onset of sleep.Nature. 1999; 401: 36-37
- Effects of bright light and melatonin on sleep propensity, temperature, and cardiac activity at night.J Appl Phys. 2001; 91: 1214-1222
- The effect of light on core body temperature is mediated by melatonin in women.J Clin Endocrinol Metab. 1993; 76: 1036-1038
- Caffeine and light effects on nighttime melatonin and temperature levels in sleep-deprived humans.Brain Res. 1997; 747: 78-84
- Acute effects of bright light and caffeine on nighttime melatonin and temperature levels in women taking and not taking oral contraceptives.Brain Res. 2000; 873: 310-317
- Melatonin-induced decrease of body temperature in women: a threshold event.Neuroendocrinology. 1994; 60: 549-552
- Effect of atenolol on nocturnal sleep and temperature in young men: reversal by pharmacological doses of melatonin.Physiol Behav. 1997; 61: 795-802
- Effect of pharmacological daytime doses of melatonin on human mood and performance.Psychopharmacology. 1993; 112: 490-496
- The hypothermic effect of melatonin on core body temperature: is more better?.J Pineal Res. 1996; 20: 192-197
- Hypothermic action of exogenously administered melatonin is dose dependent in humans.Clin Neuropharmacol. 2001; 24: 334-340
- Thermoregulatory and soporific effects of very low dose melatonin injection.Am J Physiol. 1999; 276: E249-E254
- Effect of daytime oral melatonin administration on neurobehavioral performance in humans.J Pineal Res. 1998; 25: 47-53
- Neurobehavioural performance effects of daytime melatonin and temazepam administration.J Sleep Res. 2003; 12: 207-212
- Impact of melatonin on driving performance.J Travel Med. 1998; 5: 7-13
- Effect of melatonin on the human electrocardiogram and simple reaction time responses.J Pineal Res. 1988; 5: 427-435
- Early morning melatonin administration impairs psychomotor vigilance.Behav Brain Res. 2001; 121: 167-172
- The acute soporific action of daytime melatonin administration: effects on the EEG during wakefulness and subjective alertness.J Biol Rhythms. 1997; 12: 636-643
- Sleep-inducing effects of low doses of melatonin ingested in the evening.Clin Pharmacol Ther. 1995; 57: 552-558
- Residual effects of daytime administration of melatonin on performance relevant to flight.Behav Brain Res. 2002; 131: 87-95
- Neurochemical properties of ramelteon (TAK-375), a selective MT1/MT2 receptor agonist.Neuropharmacology. 2005; 48: 301-310
- Package insert.Takeda Pharmaceuticals, 2005
- Study of the absorption, metabolism, and excretion of (14C)-ramelteon (TAK-375).Clin Pharmacol Ther. 2004; 75 ([abstract]): 22
- Disposition kinetics and tolerance of escalating single doses of ramelteon, a high-affinity MT1 and MT2 melatonin receptor agonist indicated for treatment of insomnia.J Clin Pharmacol. 2006; 46: 140-148
- Ramelteon (TAK-375) accelerates reentrainment of circadian rhythm after a phase advance of the light-dark cycle in rats.J Biol Rhythms. 2005; 20: 27-37
- The sleep-promoting action of ramelteon (TAK-375) in freely moving cats.Sleep. 2004; 27: 1319-1325
- Effect of ramelteon (TAK-375), a selective MT1/MT2 receptor agonist, on motor performance in mice.Neurosci Lett. 2006; 402: 201-204
- Acute and chronic effects of ramelteon in rhesus monkeys (Macaca mulatta): dependence liability studies.Behav Neurosci. 2006; 120: 535-541
- Behavioral pharmacology of ramelteon (TAK-375) in small animals.Ann Neurol. 2003; 54 ([abstract]): S46
- Effects of ramelteon (TAK-375) on nocturnal sleep in freely moving monkeys.Brain Res. 2004; 1027: 59-66
- Acute sleep-promoting action of the melatonin agonist, ramelteon, in the rat.J Pineal Res. 2008; 45: 125-135
- Phase response curve for ramelteon in C3H/HeN mice.Society for Biological Rhythms Program and Abstracts. 2008; 190
- Effects of ramelteon on insomnia symptoms induced by rapid, eastward travel.Society for Biological Rhythms Program and Abstracts. 2008; 70
- Circadian phase-shifting effects of repeated ramelteon administration in healthy adults.J Clin Sleep Med. 2008; 4: 456-461
- Ramelteon (TAK-375), a selective MT1/MT2-receptor agonist, reduces latency to persistent sleep in a model of transient insomnia related to a novel sleep environment.Sleep. 2005; 28: 303-307
- The effects of ramelteon in a first-night model of transient insomnia.Sleep Med. 2009; 10: 55-59
- An efficacy, safety, and dose-response study of ramelteon in patients with chronic primary insomnia.Sleep Med. 2006; 7: 17-24
- A 2-night, 3-period, crossover study of ramelteon's efficacy and safety in older adults with chronic insomnia.Curr Med Res Opin. 2007; 23: 1005-1014
- Evaluation of the efficacy and safety of ramelteon in subjects with chronic insomnia.J Clin Sleep Med. 2007; 3: 495-504
- Effects of ramelteon on patient-reported sleep latency in older adults with chronic insomnia.Sleep Med. 2006; 7: 312-318
- Ramelteon: a novel hypnotic lacking abuse liability and sedative adverse effects.Arch Gen Psychiatry. 2006; 63: 1149-1157
- Safety of ramelteon in individuals with mild to moderate obstructive sleep apnea.Sleep Breath. 2007; 11: 159-164
- The effects of ramelteon on respiration during sleep in subjects with moderate to severe chronic obstructive pulmonary disease.Sleep Breath. 2009; 13: 79-84
- Effect of ramelteon, a selective MT(1)/MT(2)-receptor agonist, on respiration during sleep in mild to moderate COPD.Sleep Breath. 2008; 12: 243-250
- The novel melatonin agonist agomelatine (S20098) is an antagonist at 5-hydroxytryptamine-2C receptors, blockade of which enhances the activity of frontocortical dopaminergic and adrenergic pathways.J Pharmacol Exp Ther. 2003; 306: 954-964
- Melatonin, sleep, and circadian rhythms: rationale for development of specific melatonin agonists.Sleep Med. 2004; 5: 523-532
- Phase shifts of 24-h rhythms of hormonal release and body temperature following early evening administration of the melatonin agonist agomelatine in healthy older men.Clin Endocrinol (Oxf). 2005; 63: 298-304
- Influence of sleep-wake and circadian rhythm disturbances in psychiatric disorders.J Psychiatry Neurosci. 2000; 25: 446-458
- Circadian rhythms in depression. Part II. Circadian rhythms in inpatients with various mental disorders.J Affect Disord. 1990; 18: 199-210
- Use of slow-release melatonin in treatment-resistant depression.J Psychiatry Neurosci. 2000; 25: 48-52
- Agomelatine: a preliminary review of a new antidepressant.CNS Drugs. 2006; 20: 981-992
- Melatonin: nature's most versatile biological signal?.FEBS J. 2006; 273: 2813-2838
- Determination of the dose of agomelatine, a melatoninergic agonist and selective 5-HT(2C) antagonist, in the treatment of major depressive disorder: a placebo-controlled dose range study.Int Clin Psychopharmacol. 2002; 17: 239-247
- Placebo-controlled trial of agomelatine in the treatment of major depressive disorder.Eur Neuropsychopharmacol. 2006; 16: 93-100
- Confirmed clinical efficacy of agomelatine (25–50 mg) in major depression: two randomized, double-blind, placebo-controlled studies.Eur Neuropsychopharmacol. 2005; 15: S416
- Efficacy of agomelatine, a MT1/MT2 receptor agonist with 5-HT2C antagonistic properties, in major depressive disorder.Int J Neuropsychopharmacol. 2007; 10: 661-673
- Melatonin agonist tasimelteon (VEC-162) for transient insomnia after sleep-time shift: two randomised controlled trials.Lancet. 2009; 373: 482-491
- Preclinical pharmacokinetics and metabolism of BMS-214778, a novel melatonin receptor agonist.J Pharm Sci. 2003; 92: 760-772
- Chronobiotic effects of the melatonin agonist LY 156735 following a simulated 9 h time shift: results of a placebo-controlled trial.Chronobiol Int. 2002; 19: 915-936
- A single blind, placebo controlled, across group dose escalation study of the safety, tolerability, pharmacokinetics and pharmacodynamics of the melatonin analog beta-methyl-6-chloromelatonin.Life Sci. 2004; 75: 1843-1856
- The efficacy and safety of the melatonin agonist beta-methyl-6-chloromelatonin in primary insomnia: a randomized, placebo-controlled, crossover clinical trial.J Clin Psychiatry. 2005; 66: 384-390
- The role of sleep in learning and memory.Science. 2001; 294: 1048-1052
- Sleep, memory, and plasticity.Annu Rev Psychol. 2006; 57: 139-166
- Sleep and memory: a molecular perspective.Trends Neurosci. 2001; 24: 237-243
- Sleep and memory: the ongoing debate.Sleep. 2005; 28: 1225-1227
- Circadian modulation of complex learning in diurnal and nocturnal Aplysia.Proc Natl Acad Sci U S A. 2005; 102: 12589-12594
- Effect of adrenalectomy on the circadian rhythm of LTP.Brain Res. 1984; 308: 392-395
- Circadian regulation of hippocampal long-term potentiation.J Biol Rhythms. 2005; 20: 225-236
- Circadian regulation of gene expression systems in the Drosophila head.Neuron. 2001; 32: 657-671
- Stimulatory effects of a melatonin receptor agonist, ramelteon, on BDNF in mouse cerebellar granule cells.Neurosci Lett. 2008; 439: 34-36
- Melatonin receptor agonist ramelteon activates the extracellular signal-regulated kinase 1/2 in mouse cerebellar granule cells.Neuroscience. 2008; 155: 1160-1164
Article info
Identification
Copyright
© 2009 Elsevier Inc. Published by Elsevier Inc. All rights reserved.
